At a glance
7
Finished Products
3
Therapy Areas
1+
Delivery Formats
C3-CURA™
Primary Platform
All ingredients
Ingredient · 04/14
Ingredient · 04/14Vitamin D3
Cholecalciferol (Vitamin D3)
Cholecalciferol (Vitamin D3)
Market Landscape
The opportunity – and where the market falls short.
- 01Essential Nutrient – bone, immunity, muscle and metabolic health
- 02High Deficiency Burden with preventive relevance
- 03High-Volume Category – routine, repeat consumption
- 04Dose-Centric Market focused on IU strength
- 05Limited Innovation – softgels, sachets, basic drops dominate
The Stabicon Edge
From market limitation to measurable transformation.
| Market Limitation | Stabicon Transformation | Impact |
|---|---|---|
| Fat-Soluble Limitation | Nano-Enabled Technology (En-Infi™) | Enhanced absorption independent of dietary fat |
| Variable Bioavailability | Enhanced Bioavailability Systems | More consistent systemic availability |
| Poor Compliance | Flexible Dosing – daily, weekly, customized | Improved adherence across segments |
| Limited Innovation | Consumer-Friendly Formats – mouth-melt, drops, sachets, chewables | Better usability and engagement |
| One-Dimensional Positioning | Expanded Use Cases | Moves beyond deficiency to preventive health |
| Low Differentiation | Platform-Led Portfolio Strategy | Premium, differentiated offerings |
Stabicon's Portfolio
Vitamin D3 reimagined across therapy areas and delivery formats.
7 finished formulations powered by Vitamin D3, organised across 3 therapy categories.
07
Products
03
Therapy Areas
01+
Formats
01 · PCOS • Menstrual • Postpartum • Endometriosis
Women's Health
02 · Bone density • Sarcopenia • Active aging
Bone & Muscle Health
03 · Vitamin D3 • Immunity • Daily vitality
Translate